$0.75
3.98%
Nasdaq, Nov 19, 03:59 pm EST. Closed.
ISIN
US59503A1051
Symbol
MBOT

Microbot Medical Inc Stock price

$0.74
-0.21 21.99% 1M
-0.99 57.03% 6M
-1.26 62.84% YTD
-1.18 61.29% 1Y
-0.63 45.74% 3Y
-5.26 87.61% 5Y
-172.06 99.57% 10Y
-52,649.26 100.00% 20Y
Nasdaq, Closing price Thu, Nov 19 2026
+0.02 3.04%

Is Microbot Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$48.5m
Enterprise Value
$-18.9m
Net debt
positive
Cash
$67.4m
Shares outstanding
67.2m
Valuation
P/E
negative
P/S | estimate
138.4 | 26.0
EV/Sales | estimate
negative | negative
EV/FCF | ex SBC
1.1 | 1.0
P/B
0.7
Financial Health
Equity Ratio
95.1%
Return on Equity
-17.0%
ROCE
-26.6%
ROIC
-
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$1.2m | 348.6%
SBC as % of FCF
-
SBC Growth 1Y
24.5%
Share Count Growth 1Y
76.9%
Shareholder Yield
-76.9%
Financials
Revenue | estimate
$350.0k | $1.9m
EBITDA
$-18.5m
EBIT
$-18.5m
Net Income
$-16.3m
Free Cash Flow | ex SBC
$-17.9m | $-19.2m
Growth
Revenue | estimate
- | -
EBITDA
-41.1%
EBIT
-40.7%
Net Income
-28.6%
Free Cash Flow
-80.6%
Margin
Gross
-185.3%
EBITDA
-5,335.3%
EBIT
-5,348.8%
Net
-4,722.3%
Free Cash Flow | ex SBC
-5,181.8% | -5,534.1%
More
EPS
$-0.2
FCF per Share
$-0.3
Short interest
9.4%
Employees
43
Rev per Employee
$0.0

Microbot Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Microbot Medical Inc forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Microbot Medical Inc forecast:

Buy
90%
Hold
10%

Microbot Medical Inc Events

Past Events
NOV
13
Q3 2026 Earnings Call
6 days ago
MAY
18
Shareholder/Analyst Call - Microbot Medical Inc.
6 months ago

Financial data from Microbot Medical Inc

Jun '26
+/-
%
0.35 0.35
-
100%
- Direct Costs 0.99 0.99
-
283%
-0.64 -0.64
-
-183%
- Selling and Administrative Expenses 12 12
105% 105%
3,429%
- Research and Development Expense 5.87 5.87
23% 23%
1,677%
-18 -18
41% 41%
-5,274%
- Depreciation and Amortization 0.05 0.05
38% 38%
14%
EBIT (Operating Income) EBIT -19 -19
41% 41%
-5,288%
Net Profit -16 -16
29% 29%
-4,669%

In millions USD.

Don't miss a Thing! We will send you all news about Microbot Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Microbot Medical Inc Stock News

Neutral
GlobeNewsWire
●
4 days ago
Company continues to expand commercial presence in the U.S. while it progresses international market entry and opportunities  Increased the number of health systems and hospital sites using LIBERTY, while utilization of the LIBERTY System rose 44% compared to the second quarter HINGHAM, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of t...
Neutral
GlobeNewsWire
●
15 days ago
HINGHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, today announced that the Canadian Intellectual Property Office (CIPO) granted the Company a patent for an adaptor for coupling a proximal portion of an elongate surgical tool (guidewire, microcatheter and the like) to a motoriz...
Neutral
GlobeNewsWire
●
24 days ago
ELMNT IR also became the first account on the West Coast, marking a geographic expansion which aligns with the Company's Full Market Release strategy.  The Company believes the OBLs represent a rapidly growing healthcare segment and opportunity as many endovascular procedures are being done outside traditional hospital settings and Ambulatory Surgery Centers.
More Microbot Medical Inc News

Company Profile

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Head office United States
CEO Mr. Gadot
Employees 43
Founded 1988
Website www.microbotmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today